Blood pressure variability predicts adverse events and cardiovascular outcomes in <scp>SPRINT</scp>
Kenechukwu Mezue(University of the Commonwealth Caribbean), Janani Rangaswami(George Washington University), Jay Horrow(Wilmington University), Gregg S. Pressman(Einstein Medical Center Philadelphia), Roy Matthew(Albany Medical Center Hospital), Abhinav Goyal
Cited by 39
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935